As the University of Missouri moves forward with plans for a new NextGen MU Research Reactor, the Molecular Imaging and Theranostics Center (MITC) Open House and Symposium showcased its present-day accomplishments.

“What perfect timing for this event,” said Matt Sanford, interim director of the MU Research Reactor (MURR), speaking to the symposium’s attendees.

Using medical isotopes — including those produced at MURR — the ultimate goal of MITC is to develop new radiopharmaceuticals for the diagnosis and treatment of human cancers.

“In the simplest terms,” said Cooper Drury, dean of the College of Arts and Science, “MITC will save and improve the lives of our families, neighbors and people around the world.”